» Authors » Kevin Schwartzman

Kevin Schwartzman

Explore the profile of Kevin Schwartzman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 2474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahukudumbi S, Chilala C, Foster N, Patel B, Mohamed M, Zary M, et al.
BMJ Glob Health . 2025 Feb; 10(2). PMID: 39947716
Introduction: Digital adherence technologies (DATs) may enable person-centred tuberculosis (TB) treatment monitoring; however, implementation challenges may undermine their effectiveness. Using the reach, effectiveness, adoption, implementation and maintenance framework, we conducted...
2.
Chilala C, Foster N, Bahukudumbi S, Mohamed M, Zary M, Kafie C, et al.
BMJ Glob Health . 2025 Feb; 10(2). PMID: 39947715
Introduction: Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3 million deaths. Digital adherence technologies (DATs) have the potential to provide person-centred care and improve...
3.
Puyat J, Brode S, Shulha H, Romanowski K, Romanowski K, Menzies D, et al.
Clin Infect Dis . 2024 Nov; PMID: 39561254
Background: Tuberculosis (TB) incidence remains disproportionately high in people migrating to Canada and other low TB incidence countries, but systematic TB screening and prevention in migrants is often cost-prohibitive for...
4.
Kafie C, Mohamed M, Zary M, Chilala C, Bahukudumbi S, Gore G, et al.
BMJ Glob Health . 2024 Oct; 9(10). PMID: 39477335
Background: Digital adherence technologies (DATs) may provide a patient-centred approach to supporting tuberculosis (TB) medication adherence and improving treatment outcomes. We synthesised evidence addressing costs and cost-effectiveness of DATs to...
5.
Zary M, Mohamed M, Kafie C, Chilala C, Bahukudumbi S, Foster N, et al.
BMJ Glob Health . 2024 Jul; 9(7). PMID: 39013639
Introduction: Digital adherence technologies (DATs), such as phone-based technologies and digital pillboxes, can provide more person-centric approaches to support tuberculosis (TB) treatment. However, there are varying estimates of their performance...
6.
Alsdurf H, Benedetti A, Buu T, Adjobimey M, Cook V, Fisher D, et al.
Front Med (Lausanne) . 2024 Jan; 10:1265476. PMID: 38283039
Introduction: The World Health Organization (WHO) declared increasing services for latent tuberculosis infection (LTBI) a priority to eliminate tuberculosis (TB) by 2035. Yet, there is little information about thehuman resource...
7.
Briere R, Emond M, Benhamed A, Blanchard P, Golbon B, Shellenberger J, et al.
Can J Surg . 2024 Jan; 66(6 Suppl 1):S54-S136. PMID: 38173057
No abstract available.
8.
Balvardi S, Kaneva P, Semsar-Kazerooni K, Vassiliou M, Al Mahroos M, Mueller C, et al.
Surgery . 2023 Dec; 175(4):1021-1028. PMID: 38154996
Background: The value of video-based self-assessment in enhancing surgical skills is uncertain. This study investigates the feasibility and estimates sample size for a full-scale randomized controlled trial to evaluate the...
9.
Nsengiyumva N, Khan A, Gler M, Tonquin M, Marcelo D, Andrews M, et al.
Emerg Infect Dis . 2023 Dec; 30(1):79-88. PMID: 38146969
Digital adherence technologies are increasingly used to support tuberculosis (TB) treatment adherence. Using microcosting, we estimated healthcare system costs (in 2022 US dollars) of 2 digital adherence technologies, 99DOTS medication...
10.
Jordan A, Nsengiyumva N, Houben R, Dodd P, Dale K, Trauer J, et al.
CMAJ . 2023 Dec; 195(48):E1651-E1659. PMID: 38081633
Background: The prevalence of tuberculosis infection is critical to the design of tuberculosis prevention strategies, yet is unknown in Canada. We estimated the prevalence of tuberculosis infection among Canadian residents...